Wolf-herman H. Fridman

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications

Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.

Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.

Journal: European urology
Published: March 24, 2025

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 05, 2022

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.

Journal: Nature medicine
Published: November 11, 2021

C1q+ macrophages: passengers or drivers of cancer progression.

C1q+ macrophages: passengers or drivers of cancer progression.

Journal: Trends in cancer
Published: September 20, 2021

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.

Journal: Immunity
Published: May 17, 2021

Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses

Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses

Journal: Bulletin du cancer
Published: February 08, 2020

Context-dependent roles of complement in cancer.

Context-dependent roles of complement in cancer.

Journal: Nature reviews. Cancer
Published: September 14, 2019

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 17, 2019

From Cancer Immune Surveillance to Cancer Immunoediting: Birth of Modern Immuno-Oncology.

From Cancer Immune Surveillance to Cancer Immunoediting: Birth of Modern Immuno-Oncology.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 25, 2018

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine.

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine.

Journal: Frontiers in oncology
Published: July 16, 2018

Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.

Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.

Journal: Journal of hepatology
Published: May 14, 2018

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Journal: Cancer immunology, immunotherapy : CII
Published: February 23, 2018
Showing 1-12 of 176

Last Updated: 09/26/2026